Hvsen Biotech: Invests 1 billion yuan to build a synthetic biology manufacturing project in Xinjiang

36Kr learned that Hvsen Biotech announced that the company will hold a board meeting on February 4th to review and approve the investment by its wholly-owned subsidiary, Xinjiang Hvsen, in the construction of the Xinjiang Synthetic Biology Manufacturing Project, with a total investment of 1 billion yuan, to be built in three phases. The project aims to meet market demand, break through capacity and efficiency bottlenecks, and achieve technology upgrades and cost control goals. The project complies with the encouraged industry policies in the western region and can enjoy local tax incentives while meeting green development requirements. The project faces market, technical, and international trade risks, and the company will respond by strengthening market monitoring, increasing R&D investment, and expanding overseas channels